Loading...
Genetic Signatures Limited
GSS.AX•ASX
HealthcareMedical - Diagnostics & Research
A$0.43
A$-0.01(-2.27%)
Genetic Signatures Limited (GSS.AX) Financial Performance & Statements
Review Genetic Signatures Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-42.35%
↓ 42.35%
Operating Income Growth
-18.22%
↓ 18.22%
Net Income Growth
-27.11%
↓ 27.11%
Operating Cash Flow Growth
18.72%
↑ 18.72%
Operating Margin
-115.13%
↓ 115.13%
Gross Margin
-21.84%
↓ 21.84%
Net Profit Margin
-154.10%
↓ 154.10%
ROE
-39.06%
↓ 39.06%
ROIC
-30.54%
↓ 30.54%
Genetic Signatures Limited (GSS.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Genetic Signatures Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $6.16M | $3.60M | $6.53M | $10.40M |
| Cost of Revenue | $13.24M | $13.05M | $15.46M | $14.22M |
| Gross Profit | -$7.08M | -$9.44M | -$8.93M | -$3.81M |
| Gross Profit Ratio | -$1.15 | -$2.62 | -$1.37 | -$0.37 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.16M | $2.66M | $3.37M | $3.06M |
| Operating Expenses | $3.16M | $2.65M | $3.37M | $2.90M |
| Total Costs & Expenses | $16.39M | $15.70M | $18.83M | $17.12M |
| Interest Income | $312000.00 | $192000.00 | $303000.00 | $240000.00 |
| Interest Expense | $35000.00 | $0.00 | $0.00 | $1000.00 |
| Depreciation & Amortization | $1.21M | $781000.00 | $824000.00 | $702000.00 |
| EBITDA | -$8.71M | -$11.12M | -$11.17M | -$5.78M |
| EBITDA Ratio | -$1.41 | -$3.14 | -$1.76 | -$0.58 |
| Operating Income | -$10.23M | -$12.09M | -$12.30M | -$6.72M |
| Operating Income Ratio | -$1.66 | -$3.35 | -$1.88 | -$0.65 |
| Other Income/Expenses (Net) | $277000.00 | $192000.00 | $303000.00 | $239000.00 |
| Income Before Tax | -$9.96M | -$11.90M | -$11.99M | -$6.48M |
| Income Before Tax Ratio | -$1.62 | -$3.30 | -$1.84 | -$0.62 |
| Income Tax Expense | -$2.56M | -$1.43M | -$4.42M | $0.00 |
| Net Income | -$7.39M | -$10.47M | -$7.57M | -$6.48M |
| Net Income Ratio | -$1.20 | -$2.90 | -$1.16 | -$0.62 |
| EPS | -$0.04 | -$0.07 | -$0.05 | -$0.04 |
| Diluted EPS | -$0.04 | -$0.07 | -$0.05 | -$0.04 |
| Weighted Avg Shares Outstanding | $210.04M | $143.64M | $146.82M | $146.80M |
| Weighted Avg Shares Outstanding (Diluted) | $210.04M | $143.64M | $146.82M | $146.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan